INTRODUCTION
The incidence of esophageal adenocarcinoma has risen rapidly in developed countries and the reasons for the increase are not well explained. Esophageal cancer predominantly afflicts males; however, the known risk factors, including obesity, reflux, and smoking cannot explain the strong male excess. Although the incidence of stomach cancer has decreased over the past 50 years in the United States and other Western countries(
1), stomach cancer still ranks fourth in cancer incidence and second in mortality worldwide. Infection with
Helicobacter pylori is an established risk factor for noncardia stomach cancer; however, only a small proportion of those infected go on to develop stomach cancer.(
1)
Iron status is typically higher in males and animal models of esophageal cancer indicate that oxidative damage caused by a combination of gastro-esophageal reflux and high iron intake promotes tumorigenesis.(
2) Iron may also play a role in stomach cancer risk by causing oxidative damage and it is thought to be an essential growth factor for
H. pylori.(
3)
Another potential mechanism involves endogenous formation of carcinogenic N-nitroso compounds (NOC), which is increased after ingestion of heme iron(4) and red and processed meats(5), the primary sources of intake.
Only a few epidemiologic studies have estimated iron intake from meat and risk of esophageal or stomach cancer.
An index for endogenously formed NOC was developed from human studies of iron intake from meats and was associated with an increased risk of stomach cancer in a European cohort study.(6) A cohort study in Iowa(7) found elevated incidence of esophageal and stomach cancer associated with high intake of heme iron but not total dietary iron.
We previously reported increased risks of esophageal and stomach adenocarcinomas associated with higher intake of red and processed meat, well-done red meat, and dietary nitrate and nitrite from animal sources.(
8,
9) Here we estimate intake of heme and total iron from meat in relation to risk of these cancers using a new database of heme iron levels developed at the National Cancer Institute (NCI).